Skip to Main Content

Paper Details

Identification of on-target mutagenesis during correction of a beta-thalassemia splice mutation in iPS cells with optimised CRISPR/Cas9-double nickase reveals potential safety concerns.
APL Bioeng
11
2018
Author NameAffiliation
Dmitry A OvchinnikovAustralian Institute for Bioengineering and Nanotechnology, The University of Queensland
Ernst J WolvetangAustralian Institute for Bioengineering and Nanotechnology, The University of Queensland
  • 1 - 2

Datasets

Release 1.2